Living-donor Liver Transplant for Patients With Liver Cancer
Living-donor Liver Transplant for Patients With Liver Cancer is organized by OptumHealth Education (OHE).
Activity opens: 11/01/2021
Activity expires: 11/01/2024
Target Audience:
This activity is designed to meet the educational needs of case managers, counselors, nurses, nurse practitioners, pharmacists, pharmacy technicians, physicians, PAs, psychologists, social workers, therapists and other health care professionals who have an interest in liver cancer and liver transplantation.
Activity Description:
Living-donor liver transplants are life-saving treatments that can greatly decrease transplant waitlist times for recipients and allow donors to meaningfully contribute to others’ lives. Christopher Hughes, MD, the surgical director of the UPMC Liver Transplant Program, will discuss the utilization of living-donor liver transplant for patients diagnosed with advanced liver cancer, including unresectable metastatic colorectal cancer, hepatocellular carcinoma, intrahepatic cholangiocarcinoma or mixed cholangio/hepatocellular carcinoma, hilar cholangiocarcinoma, and unresectable neuroendocrine tumor.
This activity will provide an overview of the living-donor liver transplant procedure, the advantages and disadvantages of living-donor liver transplant, and the optimal timing for offering living donations to patients with liver cancer. Dr. Hughes will discuss the innovative approach advanced by experts at UPMC in which patients with liver cancer are offered the option of a living-donor transplant. He will discuss the experience and expertise offered by the UPMC Liver Transplant Program and their collaborative approach to working with referring physicians.
Learning Objectives
At the end of this educational activity, participants should be able to:
• Review the current state of liver transplantation and living-donor liver transplantation in the United States and the advantages and disadvantages of living-donor transplant.
• Recognize the indications for a living-donor liver transplant for patients with advanced liver cancer and the optimal timing for a patient to receive a living-donor liver transplant.
• Examine UPMC’s protocols for living-donor liver transplant for unresectable metastatic colorectal cancer, hepatocellular carcinoma, intrahepatic cholangiocarcinoma or mixed cholangio/hepatocellular carcinoma, hilar cholangiocarcinoma, and unresectable neuroendocrine tumor.
• Realize the benefits of living-donor liver transplant for patients with liver cancer who have exhausted all other treatment options.